Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
2024 Netherlands Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
2024 Dominican Republic Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea ... Read More
-
2024 Malaysia Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
Melanoma Drugs Global Market Report 2024
... Bristol-Myers Squibb Company; F. Hoffmann-La Roche A; GlaxoSmithKline plc; Janssen Biotech Inc. Melanoma Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need ... Read More
-
Sarcoma Drugs Global Market Report 2024
... AG; Eisai Co. Ltd.; Eli Lilly and Company; GlaxoSmithKline plc Sarcoma Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess ... Read More
-
Global Breast Cancer Therapeutics Market 2024-2028
... breast cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Precision Cancer Diagnostic Test Market Report 2024-2034
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Adoption of Liquid Biopsies Propels ... Read More
-
Europe Genomic Cancer Panel and Profiling Market: Analysis and Forecast, 2023-2033
... billion and is expected to attain a value of $6.50 billion in 2033. The market is anticipated to grow at a CAGR of 9.42% during the forecast period 2023-2033. This growth is being driven by ... Read More
-
Immunotherapy Drugs Market (Drug Type: Monoclonal Antibodies, Immunomodulators, Cell Therapy and Others; and Therapy Area: Cancer, Autoimmune Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
CAR T-cell Therapy Market by Indication (Hematologic Malignancies, Solid Tumors), End-Use (Cancer Treatment Centers, Hospitals) - Global Forecast 2024-2030
... to reach USD 5.35 billion in 2024, at a CAGR 5.00% to reach USD 7.15 billion by 2030. Global CAR T-cell Therapy Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Multiple Myeloma Therapeutics Market by Type (Chemotherapy, Radiation, Stem Cell Transplant & Supportive Treatment), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies & Drug Stores) - Global Forecast 2024-2030
... was estimated at USD 21.54 billion in 2023 and expected to reach USD 22.95 billion in 2024, at a CAGR 7.06% to reach USD 34.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Central Nervous System Therapeutics Market by Diseases (Cancer, Degenerative Diseases, Infectious Diseases), Drug Class (Analgesics, Anesthetics, Anti-Epileptics), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 76.41 billion in 2024, at a CAGR 9.37% to reach USD 131.39 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Central ... Read More
-
Cancer Monoclonal Antibodies Market by Type (Chimeric, Human, Humanized), Application (Blood Cancer, Breast Cancer, Colorectal Cancer), End-user - Global Forecast 2024-2030
... and expected to reach USD 78.60 billion in 2024, at a CAGR 12.89% to reach USD 163.28 billion by 2030. Global Cancer Monoclonal Antibodies Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Robotic Surgery for Cervical Cancer Market by Component (Services, Systems), Surgery Type (Cryosurgery, Laser Surgery, Radical Hysterectomy), End User - Global Forecast 2024-2030
... 12.14 billion in 2023 and expected to reach USD 13.09 billion in 2024, at a CAGR 7.32% to reach USD 19.92 billion by 2030. Global Robotic Surgery for Cervical Cancer Market FPNV Positioning Matrix The ... Read More
-
Immune Checkpoint Inhibitors for Lung Cancer Market by Products (Atezolizumab, Durvalumab, Nivolumab), Type (CTLA-4 Inhibitors, PD-1 Inhibitors, PD-L1 Inhibitors), End-Users - Global Forecast 2024-2030
... at USD 1.01 billion in 2023 and expected to reach USD 1.15 billion in 2024, at a CAGR 14.55% to reach USD 2.62 billion by 2030. Global Immune Checkpoint Inhibitors for Lung Cancer Market FPNV ... Read More
-
Nanobiotechnology Market by Product (Nano-Enabled Drugs, Nanodevices, Nanoparticles), Application (Agriculture, Cancer Treatment, Diagnostics) - Global Forecast 2024-2030
... billion in 2024, at a CAGR 16.04% to reach USD 9.91 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Nanobiotechnology Market. It offers a comprehensive assessment of vendors, ... Read More
-
Breast Cancer Liquid Biopsy Testing Devices Market by Offerings (Assay & Reagents Kits, Instruments), Circulating Biomarker (Circulating Tumar DNA, Circulating Tumor Cell, Extracellular Vesicles), End-User, Appplication - Global Forecast 2024-2030
... Testing Devices Market size was estimated at USD 858.76 million in 2023 and expected to reach USD 1,023.60 million in 2024, at a CAGR 19.59% to reach USD 3,004.57 million by 2030. Global Breast Cancer ... Read More
-
Oncology Biosimilars Market by Application (Cancer Treatment Drugs, Supportive Care Drugs), End-User (Hospitals, Retail Pharmacies) - Global Forecast 2024-2030
... reach USD 5.48 billion in 2024, at a CAGR 18.11% to reach USD 14.91 billion by 2030. Global Oncology Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Oncology Biosimilars ... Read More
-
Oncology Based In-Vivo CRO Market by Services (Biomarker Development, Clinical Trial Management, Pharmacokinetics Studies), Indication (Hematological Malignancies, Rare Cancer, Solid Tumor), End-User - Global Forecast 2024-2030
... at USD 1.27 billion in 2023 and expected to reach USD 1.41 billion in 2024, at a CAGR 11.34% to reach USD 2.70 billion by 2030. Global Oncology Based In-Vivo CRO Market FPNV Positioning Matrix ... Read More
-
Prostate Cancer Therapeutics Market by Drug Class (Chemotherapy, Hormonal Therapy, Immunotherapy), Distribution Channel (Drug Stores & Retail Pharmacies, Hospitals Pharmacies, Online Pharmacies) - Global Forecast 2024-2030
... USD 10.00 billion in 2023 and expected to reach USD 10.62 billion in 2024, at a CAGR 6.32% to reach USD 15.36 billion by 2030. Global Prostate Cancer Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Hematological Malignancies Market by Types (Leukemia, Lymphoma, Multiple Myeloma), Treatment (Bone Marrow Transplantation, Chemotherapy, Chimeric Antigen Receptor (Car) T Cell Therapy), Diagnosis, End-Users - Global Forecast 2024-2030
... USD 15.33 billion in 2023 and expected to reach USD 16.84 billion in 2024, at a CAGR 9.92% to reach USD 29.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Acute Lymphoblastic Leukemia Treatment Market (ALL) by Types of Cell (B-cell ALL, Philadelphia chromosome: Positive (Ph+) and negative (Ph-), T-cell ALL), Therapy (Chemotherapy, Radiation Therapy, Stem Cell Transplantation), End-User - Global Forecast 202
... Lymphoblastic Leukemia Treatment Market size was estimated at USD 3.22 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 6.45% to reach USD 4.99 billion by 2030. FPNV Positioning ... Read More
-
Antibody Drug Conjugates Contract Manufacturing Market by Linker (Cleavable, Non-cleavable), Condition (Breast Cancer, Lymphoma, Myeloma), End Use - Global Forecast 2024-2030
... in 2023 and expected to reach USD 13.06 billion in 2024, at a CAGR 11.82% to reach USD 25.99 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antibody ... Read More
-
In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.19 billion in 2024, at a CAGR 7.01% to reach USD 4.85 billion by 2030. Global In Silico Clinical Trials Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Combination Antibody Therapy Market by Type (Antibody-Drug Conjugates, Bispecific Antibodies, Chemotherapy-Monoclonal Antibodies), Indication (Cancer, HIV), Route of Administration, Distribution Channel, End-Use - Global Forecast 2024-2030
... 209.37 billion in 2023 and expected to reach USD 231.55 billion in 2024, at a CAGR 9.30% to reach USD 390.18 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
Research Assistance
